Search research articles
Contact Us
Filters
Showing results (121-130 of 138) with videos related to
Page
of 14
Sort By:
Anticancer Research
|
September 9, 2018
Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes
Marta Mendiola, Andrés Redondo, Victoria Heredia-Soto, et al.
Current Oncology (Toronto, Ont.)
|
December 27, 2024
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM
Konstantinos Kamposioras, Panagiotis Ntellas, Katerina Dadouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2020
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation
Jorge Barriuso, Raghavendar T Nagaraju, Shreya Belgamwar, et al.
Plos One
|
December 30, 2008
Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma
Marta Mendiola, Jorge Barriuso, Andrés Redondo, et al.
Cancers
|
February 25, 2023
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study
Kok Haw Jonathan Lim, Panagiotis Ntellas, Daniel Anderson, et al.
BMC Cancer
|
July 4, 2015
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis
Jaume Capdevila, Isabel Sevilla, Vicente Alonso, et al.
International Journal of Cancer
|
September 1, 2019
From presentation to paper: Gender disparities in oncological research
Willemieke P M Dijksterhuis, Charlotte I Stroes, Wan-Ling Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2011
Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies
David Olmos, Douglas Barker, Rohini Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2011
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies
Timothy A Yap, David Olmos, Andre T Brunetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Jaume Capdevila, Oriol Arqués, Jose Ramón Hernández Mora, et al.
Page
of 14
Search research articles
Search
Showing results (121-130 of 138) with videos related to
Sort By:
Page
of 14
Anticancer Research
|
September 9, 2018
Predicting Response to Standard First-line Treatment in High-grade Serous Ovarian Carcinoma by Angiogenesis-related Genes
Marta Mendiola, Andrés Redondo, Victoria Heredia-Soto, et al.
Current Oncology (Toronto, Ont.)
|
December 27, 2024
Longitudinal Follow-Up of the Psychological Well-Being of Patients with Colorectal Cancer: Final Analysis of PICO-SM
Konstantinos Kamposioras, Panagiotis Ntellas, Katerina Dadouli, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 1, 2020
Early Adaptation of Colorectal Cancer Cells to the Peritoneal Cavity Is Associated with Activation of "Stemness" Programs and Local Inflammation
Jorge Barriuso, Raghavendar T Nagaraju, Shreya Belgamwar, et al.
Plos One
|
December 30, 2008
Angiogenesis-related gene expression profile with independent prognostic value in advanced ovarian carcinoma
Marta Mendiola, Jorge Barriuso, Andrés Redondo, et al.
Cancers
|
February 25, 2023
The Mental Health Burden of Patients with Colorectal Cancer Receiving Care during the COVID-19 Pandemic: Results of the PICO-SM Study
Kok Haw Jonathan Lim, Panagiotis Ntellas, Daniel Anderson, et al.
BMC Cancer
|
July 4, 2015
Evaluation of the efficacy and safety of lanreotide in combination with targeted therapies in patients with neuroendocrine tumours in clinical practice: a retrospective cross-sectional analysis
Jaume Capdevila, Isabel Sevilla, Vicente Alonso, et al.
International Journal of Cancer
|
September 1, 2019
From presentation to paper: Gender disparities in oncological research
Willemieke P M Dijksterhuis, Charlotte I Stroes, Wan-Ling Tan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 5, 2011
Phase I study of GSK461364, a specific and competitive Polo-like kinase 1 inhibitor, in patients with advanced solid malignancies
David Olmos, Douglas Barker, Rohini Sharma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 9, 2011
Phase I trial of a selective c-MET inhibitor ARQ 197 incorporating proof of mechanism pharmacodynamic studies
Timothy A Yap, David Olmos, Andre T Brunetto, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 2, 2019
Epigenetic <i>EGFR</i> Gene Repression Confers Sensitivity to Therapeutic BRAFV600E Blockade in Colon Neuroendocrine Carcinomas
Jaume Capdevila, Oriol Arqués, Jose Ramón Hernández Mora, et al.
Page
of 14